Hyderabad: After closing the emergency use permit (EUA) and clinical requests for phase-3 requests for Bharat Biotech Covaxin, Brazilian Health…
Hyderabad: After closing an emergency use business (EUA) and the clinical test request for phase-3 for Bharat Biotech's Covaxin, Brazilian…
SAO PAULO: Brazilian Health Agency Council Anvisa has provisarally suspended its import authorization for the Covid-19 Bharat Biotech vaccine while…
Hyderabad: After suspending the covaxin clinical test after the termination of Bharat Biotech's Mou with Brazilian Partners Precisa Medicamentos, Brazilian…
Hyderabad: After Bharat Biotech stopped the MoU with Brazilian partner Precisa Medicamentos on Friday, Brazilian Health Regulator Anvisa (Agencia Nacional…
PARIS: The developers of Russia's Sputnik V coronavirus vaccine have repeatedly failed to provide data that regulators deem to be…
HYDERABAD: After dithering initially, Brazil’s health regulator Anvisa (Agência Nacional de Vigilância Sanitária) has finally given the green light to…
HYDERABAD: In a move that paves the way for exports of indigenously developed Covid-19 vaccine Covaxin into Brazil, its own…
Bharat Biotech Documents 2 new GMP Certificate Asks Together with Brazil’s Anvisa to Get Covaxin
HYDERABAD: Bharat Biotech has now approached the Brazilian wellness regulator looking for Good Manufacturing Practices (GMP) certificates for indigenously developed…
